Handbook of Clinical medicine
KEYWORDS: patient, disease, patients, history, pain, heart, symptoms, ask, time, treatment, risk, examination, aortic, iinnddbb, pulse

macological measures’ later in this topic). • Home-based fall-prevention programme, with visual assessment and a home visit. NB: hip-protectors are unreliable for preventing fractures.16 Pharmacological measures: • Bisphosphonates: alendronic acid is 1st line (10mg/d or 70mg/wk; not if eGFR <35). Use also for prevention in long-term steroid use. If intolerant, try etidronate or rise- dronate. Tell patient to swallow pills with plenty of water while remaining upright for >30min and wait 30min before eating or other drugs. (SE: photosensitivity; GI upset; oesophageal ulcers—stop if dysphagia or abdo pain; rarely, jaw osteonecrosis). • Calcium and vitamin D: rarely used alone for prophylaxis, as questionable effi cacy and some evidence of a small CV risk. Off er if evidence of defi ciency, eg calcium 1g/d + vit D 800U/d. Target serum 25-hydroxy-vitamin D level ≥75nmol/L. • Strontium ranelate: due to an increased risk of cardiac problems it should only be used in those with severe intolerance of other agents and without cardiovascular disease. • Hormone replacement therapy (HRT) can prevent (not treat) osteoporosis in post- menopausal women. Relative risk of breast cancer is 1 . 4 if used >10yrs;  CV risk. • Raloxifene is a selective oestrogen receptor modulator (SERM) that
